Inspire and Japan Lifeline Co Ltd worked closely with the Minister of Health Labour and Welfare to advance the reimbursement application for Inspire therapy, which was approved by an expert panel this month.
This revised labeling ensures that patients who receive the Genio system and those already implanted can now undergo full-body 1.5T and 3T MRI diagnostic scans within approved parameters.
UnitedHealthcare is one of the businesses of UnitedHealth Group, a diversified health care company that provides coverage for approximately 41 million members.
The trial seeks to explore whether transvenous stimulation can improve airway physiology.
Read More
Highlights from the 5-year data show sustained improvements that were consistent with the published 6-, 12-, 24-, and 36-month results.
Read More
After more than 20 years of troubled sleep, Dwight Johnson can finally sleep peacefully throughout the night.
Read MoreHealth plan provider Humana Inc will provide coverage for Inspire upper airway stimulation therapy, effective August 27.
Read MoreThe reimbursement process is anticipated to be completed during 2021 and Inspire expects to launch its therapy in Australia thereafter.
Read More
Physicians who use Inspire upper airway stimulation, Respicardia’s remedē, and Avery’s diaphragm pacemaker share their stories.
Read More
Positive airway pressure therapy isn’t for everyone, says AASM award winner Richard Berry, MD, FAASM, who also shares his insights on positional therapies, neurostimulation, and interface selection.
Read More
Inspire has multiple additional digital health solutions in development that are aimed at improving patient outcomes and medical practice efficiency.
Read MoreThe US Food and Drug Administration (FDA) has approved an expanded age range for Inspire Upper Airway Stimulation Therapy for obstructive sleep apnea to include 18-21 year old patients.
Read More
Avery Biomedical Devices has earned FDA approval for its next-generation diaphragm pacemaker transmitter, Spirit, and indications for use include chronic respiratory insufficiency due to central sleep apnea.
Read MoreHealthcare professionals are invited to watch this Ask Us Anything, which is a recording of the live event in which health professionals had their questions about Inspire answered live!
Read MoreThree Medicare Administrative Contractors (MACs) have announced the effective release date of March 15, 2020, for their final local coverage determinations (LCD) policies covering Inspire Medical Systems Inc’s Inspire...
Read More![30-Minute Ask Us Anything: Inspire Medical Systems Inc [On-Demand Webinar]](https://www.sleepreviewmag.com/wp-content/uploads/2020/01/InspireRemote-627x376.png)
Two expert physician panelists answer audience questions about Inspire Medical Systems Inc, the makers of upper airway stimulation therapy for obstructive sleep apnea.
Read More
Data demonstrating the benefits and safety of Nyxoah SA’s Genio hypoglossal nerve...
Read More
Inspire Medical Systems, Inc, a medical technology company focused on the development and...
Read More